dehydroepiandrosterone has been researched along with Aldosteronism in 11 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The practicability and tolerability of trilostane, a competitive inhibitor of 3 beta-hydroxysteroid-delta 5-dehydrogenase, for the therapy of primary aldosteronism was assessed in 1 patient with aldosterone-producing adenoma (APA) and 3 subjects with idiopathic adrenal hyperplasia (IHA)." | 7.67 | Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor). ( Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M, 1985) |
| "Six patients with primary aldosteronism (PA), one with idiopathic hyperaldosteronism (IHA), one with glucocorticoid responsible hyperaldosteronism (GRHA) and eight with essential hypertension (EH) were treated with trilostane (MWD-1822) (4 alpha, 5-epoxy-17 beta-hydroxy-3-oxo-5 alpha-androstane-2 alpha-carbonitrile), an inhibitor of adrenal steroid biosynthesis, for 9-47 days with a daily dose of 30-960 mg." | 7.66 | [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)]. ( Fukuchi, S; Haruyama, K; Shigetomi, S; Yamazaki, M, 1982) |
| "We examined if measurement of adrenal androgens adds to subtype diagnostics of primary aldosteronism (PA) under cosyntropin-stimulated adrenal venous sampling (AVS)." | 4.12 | Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling. ( Hinkka, T; Kokko, E; Leijon, H; Matikainen, N; Nevalainen, PI; Pörsti, I; Schalin-Jäntti, C; Soinio, M; Vesterinen, T; Viukari, M, 2022) |
| "The practicability and tolerability of trilostane, a competitive inhibitor of 3 beta-hydroxysteroid-delta 5-dehydrogenase, for the therapy of primary aldosteronism was assessed in 1 patient with aldosterone-producing adenoma (APA) and 3 subjects with idiopathic adrenal hyperplasia (IHA)." | 3.67 | Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor). ( Ishikawa, S; Katayama, T; Kazama, T; Koike, H; Nakada, T; Yoshikawa, M, 1985) |
| "Six patients with primary aldosteronism (PA), one with idiopathic hyperaldosteronism (IHA), one with glucocorticoid responsible hyperaldosteronism (GRHA) and eight with essential hypertension (EH) were treated with trilostane (MWD-1822) (4 alpha, 5-epoxy-17 beta-hydroxy-3-oxo-5 alpha-androstane-2 alpha-carbonitrile), an inhibitor of adrenal steroid biosynthesis, for 9-47 days with a daily dose of 30-960 mg." | 3.66 | [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)]. ( Fukuchi, S; Haruyama, K; Shigetomi, S; Yamazaki, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Viukari, M | 1 |
| Kokko, E | 1 |
| Pörsti, I | 1 |
| Leijon, H | 1 |
| Vesterinen, T | 1 |
| Hinkka, T | 1 |
| Soinio, M | 1 |
| Schalin-Jäntti, C | 1 |
| Matikainen, N | 1 |
| Nevalainen, PI | 1 |
| KOMOR, K | 1 |
| Shigetomi, S | 1 |
| Fukuchi, S | 1 |
| Haruyama, K | 1 |
| Yamazaki, M | 1 |
| New, MI | 1 |
| Levine, LS | 1 |
| Terayama, Y | 1 |
| Furusawa, M | 1 |
| Morita, S | 1 |
| Kido, K | 1 |
| Tanaka, T | 1 |
| Eba, H | 1 |
| Nigawara, K | 1 |
| Hitomi, H | 1 |
| Sugawara, S | 1 |
| Yagihashi, Y | 1 |
| Kogawa, T | 1 |
| Kawamata, A | 1 |
| Tulachan, Y | 1 |
| Funyu, T | 1 |
| Hanson, JA | 1 |
| Weber, A | 1 |
| Reznek, RH | 1 |
| Cotterill, AM | 1 |
| Ross, RJ | 1 |
| Harris, RJ | 1 |
| Armstrong, P | 1 |
| Savage, MO | 1 |
| Kołomecki, K | 1 |
| Stepień, H | 1 |
| Narebski, JM | 1 |
| Nakada, T | 1 |
| Kazama, T | 1 |
| Koike, H | 1 |
| Yoshikawa, M | 1 |
| Ishikawa, S | 1 |
| Katayama, T | 1 |
| Aiba, M | 1 |
| Iri, H | 1 |
| Suzuki, H | 1 |
| Kageyama, K | 1 |
| Kawai, T | 1 |
| Abe, O | 1 |
| Murai, M | 1 |
| Tazaki, H | 1 |
| Saruta, T | 1 |
| Melby, JC | 1 |
| Metcalf, MG | 1 |
2 reviews available for dehydroepiandrosterone and Aldosteronism
| Article | Year |
|---|---|
Hypertension of childhood with suppressed renin.
Topics: 18-Hydroxydesoxycorticosterone; 20-alpha-Dihydroprogesterone; Adolescent; Adrenal Cortex; Adrenal Hy | 1980 |
Assessment of adrenocortical function.
Topics: 17-Ketosteroids; Addison Disease; Adolescent; Adrenal Glands; Adrenal Insufficiency; Adult; Aldoster | 1971 |
9 other studies available for dehydroepiandrosterone and Aldosteronism
| Article | Year |
|---|---|
Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling.
Topics: Adrenal Glands; Aldosterone; Androgens; Androstenedione; Cosyntropin; Dehydroepiandrosterone; Humans | 2022 |
[ON THE TREATMENT OF ADRENAL CORTEX DISEASES].
Topics: Addison Disease; Adrenal Cortex Diseases; Adrenal Insufficiency; Adrenocortical Hyperfunction; Adren | 1963 |
[The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Topics: Adult; Aldosterone; Blood Pressure; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hyp | 1982 |
[Corticoids secretion in primary aldosteronism. I. Diurnal variation and the effect of dexamethasone (author's transl)].
Topics: Adrenal Cortex Hormones; Adrenalectomy; Adult; Aldosterone; Circadian Rhythm; Corticosterone; Cortis | 1980 |
Magnetic resonance imaging of adrenocortical adenomas in childhood: correlation with computed tomography and ultrasound.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hor | 1996 |
Vascular endothelial growth factor and basic fibroblast growth factor evaluation in blood serum of patients with hormonally active and inactive adrenal gland tumours.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adult; Aged; Carc | 2000 |
Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor).
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adreno | 1985 |
Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Histologic evaluation of benignancy and comparison with mast cell distribution in adrenal glands and neoplastic counterparts of 67 surgical specimens.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Carcinoma, Renal Cell; Dehydroepiandro | 1985 |
Rapid gas chromatographic assay for dehydroepiandrosterone in urine.
Topics: Adolescent; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Chorionic Gonadotropi | 1971 |